コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ing the activity of let-363 (TOR) or daf-15 (RAPTOR).
2 a rapamycin-sensitive complex that involves Raptor.
3 king out rictor or Sin1 but not by silencing raptor.
4 to 43% in two decades of this once-abundant raptor.
5 cross-linking and interaction of 4E-BP1 with Raptor.
6 sult of enhanced interaction of p70S6K1 with raptor.
7 ween the two substrates for interaction with raptor.
8 phorylation site, RPGT908T, for ICK in human Raptor.
9 ines correlate well with theory generated by RAPTOR.
10 iation between mTOR and the mTORC1 co-factor Raptor.
11 b1, AMP-activated protein kinase (AMPK), and raptor.
12 in vitro is unaffected by the elimination of raptor.
13 curs through mTOR itself rather than through raptor.
14 an amino acid-dependent manner with mTOR and raptor.
15 enetic reduction of the mTOR-binding protein Raptor.
16 ey component of the mTOR complex 1 (mTORC1), Raptor.
17 mbly and signaling by folding both mLST8 and Raptor.
18 ORC1 inhibitor rapamycin or by knocking down raptor.
19 assay) and mTOR pathway protein expression (raptor, 4e-bp-1, and p70S6K proteins) along with enhance
20 Mass spectrometric analysis of cross-linked Raptor-4E-BP1 led to the identification of several cross
21 3% (median 19%) improvement as compared with RAPTOR (a well-known threading method) and even a mean 1
22 r stress, ABA-activated SnRK2s phosphorylate Raptor, a component of the TOR complex, triggering TOR c
24 addition, we found that MARK4 phosphorylates Raptor, a key component of mTORC1, and this phosphorylat
25 owth factor-induced nuclear translocation of Raptor, a regulatory scaffolding component in mTORC1, an
26 ed serine phosphorylation of RAPTOR in a new Raptor (AA) mouse model, in which AMPK phospho-serine si
29 uent signaling to AMPK substrates, including Raptor, acetyl coenzyme A carboxylase, and PGC-1alpha, i
30 ic acetyl-CoA levels, which led to decreased Raptor acetylation and reduced lysosomal localization of
31 fects on autophagy are mediated by decreased raptor acetylation causing mTORC1 inhibition, rather tha
32 tutive and inducible deletion of conditional Raptor alleles in renal tubular epithelial cells, we dis
37 of the Hippo pathway, phosphorylate S606 of Raptor, an essential component of mTORC1, to attenuate m
38 ctive mutant displays higher affinity toward Raptor, an essential scaffolding component of mTORC1 tha
39 neage-specific deletion of the gene encoding RAPTOR, an essential signaling adaptor for rapamycin-sen
41 we used live imaging of the mTORC1 component RAPTOR and a cell permeant fluorescent analogue of di-le
42 PK) activation, increased phosphorylation of raptor and acetyl-CoA carboxylase, and decreased phospho
43 n the DDB1-CUL4 ubiquitin ligase complex and raptor and counteracts DDB1-CUL4-mediated raptor ubiquit
44 tly by phosphorylation of the mTORC1 subunit Raptor and indirectly by phosphorylation of the regulato
47 as evidenced by decreased phosphorylation of raptor and mTOR and the downstream targets S6 kinase and
49 S100B calcium-binding protein, mTOR proteins RAPTOR and P70S6, the AMP-kinase catalytic subunit AMPKA
50 ese effects were accompanied by decreases in raptor and PRAS40 and an increase in RagC associated wit
51 159/T2164 phosphorylation modulates the mTOR-raptor and raptor-PRAS40 interactions and augments mTORC
55 SP9X can co-immunoprecipitate mTOR with both Raptor and Rictor, components of mTOR complexes 1 and 2
57 This work used short hairpin RNA against Raptor and Rictor, unique components of mTORC1 and mTORC
59 l diameter was significantly reduced in both Raptor and Tsc1 conditional knockout mice, albeit with v
60 urine liver requires AMPK regulation of both RAPTOR and TSC2 to fully inhibit mTORC1, and this regula
61 a core subunit Raptor, whereas mTORC2 lacks Raptor and, instead, has Rictor and SIN1 as distinct ess
62 ds to regulatory-associated protein of mTOR (Raptor) and causes it to translocate to the nucleus upon
63 t of rapamycin (mTOR) complexes mTORC1 (mTOR-Raptor) and mTORC2 (mTOR-Rictor) in PAVSMC proliferation
64 ng rapamycin or stable inhibition of mTORC1 (Raptor) and mTORC2 (Rictor), attenuated migration and in
65 ion of key mTOR pathway components (REHB and RAPTOR) and of lung metastasis mediators (FSCN1 and SPAR
67 A significant downregulation of p-mTOR, p-Raptor, and p-S6RP was observed, which was restored to n
71 rug insensitive, higher levels of mTOR-bound raptor are detected than in cells where rapamycin stimul
72 ous Caenorhabditis elegans RHEB-1 and DAF-15/Raptor are expressed ubiquitously and localize to lysoso
75 pamycin (mTOR) pathway by phosphorylation of raptor as a transient cell's compensatory mechanism to p
78 (mTOR) functions in two distinct complexes: Raptor-associated mTORC1 and Rictor-associated mTORC2.
82 he subunits of these complexes are mLST8 and Raptor, beta-propeller proteins that stabilize the mTOR
90 malian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery
92 (mTORC1) signaling by conditionally deleting Raptor causes severe defects in iNKT-cell development at
93 ers of NFATc1 and NFATc2 in T cells, such as Raptor, CHEK1, CREB1, RUNX1, SATB1, Ikaros, and Helios.
94 tects the nucleotide state of RagA while the Raptor "claw" threads between the GTPase domains to dete
96 al evidence that ICK interacts with the mTOR/Raptor complex in cells and phosphorylates Raptor in vit
103 blasts or in 293 cells by down-regulation of raptor decreased the levels of the transcription factor
105 with rapamycin recapitulated the effects of RAPTOR deficiency, and both strategies led to the ablati
109 of a transgenic BCR or a BclxL transgene on Raptor-deficient B cells failed to rescue B cell develop
114 ter turnover rate and increased apoptosis of Raptor-deficient LCs, which might additionally affect th
123 r Thr-908 both in vitro and in vivo and when Raptor exists in protein complexes with or without mTOR.
124 ion systems were used to specifically target Raptor(fl/fl) (mTORC1), either in all tissues upon poly(
126 the early stages of development in Vav-cre(+)Raptor(fl/fl) mice, revealed that these mice do not surv
127 aling was blocked, by crossing Raptor loxed (Raptor(flox/flox)) mice with CX3CR1(CreER) mice, which e
129 elper 2 (Th2) cell differentiation, although Raptor function is less important for continuous prolife
130 GDI2 by rictor is not related to the Sin1 or raptor function that excludes a role of mTORC2 or mTORC1
132 pression in Fib-MCs in experiments utilizing raptor gene silencing and overexpression of dominant-inh
133 ile downregulation of mTORC1 activity, using Raptor genetic mouse model or mTORC1 inhibitor treatment
134 ve genomic analysis and comparisons with non-raptor genomes identify common molecular signatures that
136 at the balance of free and mTORC1-associated Raptor governs hepatic lipid accumulation, and uncover t
137 ion of either mTOR or the associated protein Raptor greatly diminishes embryonic skeletal growth asso
138 nd angiogenesis in vivo, whereas the loss of Raptor had only a modest effect on endothelial cells (EC
139 horylation in cells, comparable depletion of raptor has no effect; moreover, the ability of mTOR to p
140 lowing: (i) LARP1 associates with mTORC1 via RAPTOR; (ii) LARP1 interacts with TOP mRNAs in an mTORC1
143 arget of rapamycin (mTOR) or rictor, but not raptor, implicating mTORC2 as the target of rapamycin fo
144 rect AMPK-mediated serine phosphorylation of RAPTOR in a new Raptor (AA) mouse model, in which AMPK p
145 ue-specific deletion of the mTORC1 regulator Raptor in alpha cells (alphaRaptorKO), we showed that mT
146 disruption of the mTOR coactivating protein Raptor in developing mouse B cells resulted in a develop
148 sgenic mice, PRAS40(T246A) remained bound to raptor in keratinocytes even after treatment with TPA, c
149 EAT repeats of Tor2 that are engaged by Kog1/Raptor in mammalian TORC1, explaining the mutual exclusi
156 , conditional depletion of endogenous DAF-15/Raptor in the soma revealed that TORC1 is required at ea
159 n the regulatory associated protein of mTOR (Raptor) in microglia, whose mTORC1 signaling was blocked
160 nent, regulatory-associated protein of mTOR (Raptor), in mouse HSCs and its loss causes a nonlethal p
162 rget of rapamycin complex 1 (mTORC1) subunit Raptor induces cell growth and is a downstream target of
165 TORC1 before complete disruption of the mTOR-raptor interaction, whereas mTORC2 stoichiometry is unaf
168 , our study reveals that enterocyte specific Raptor is required for initiating a type 2 immune respon
169 n (in particular residues from 89 to 180) of Raptor is the major site of interaction with 4E-BP1.
170 athway, in that mTORC1 (with adaptor protein Raptor) is the main complex mediating the maturation and
171 mplex 1 (mTORC1), defined by the presence of Raptor, is an evolutionarily conserved and nutrient-sens
172 h was also observed in rictor mutants, while raptor knockdown did not phenocopy the TSC mutant phenot
173 this signaling pathway with mTOR inhibitors, raptor knockdown or p70S6K inhibitors elevated PD-L1 lev
177 eated skeletal muscle specific and inducible raptor knockout mice to eliminate signaling by mTORC1, a
178 fference in tumor growth between conditional Raptor KO and control mice in the s.c. tumor models, alt
179 tumor microenvironment of mTORC1 conditional Raptor KO mice due to downregulated CD115 expression on
181 4/80(high)) were accumulated in the lungs of Raptor KO mice in the LLC lung metastasis model, leading
182 ipocyte-specific mTOR KO, adipocyte-specific Raptor KO, and adipocyte-specific tuberous sclerosis com
183 specific deletion of the essential component raptor leads to a profound loss of T(reg)-cell suppressi
184 1 activity in DCs by conditional deletion of Raptor leads to a progressive loss of LCs in the skin of
187 with age and in obesity; restoration of free Raptor levels reduces liver triglyceride content, throug
188 se mTORC1 signaling was blocked, by crossing Raptor loxed (Raptor(flox/flox)) mice with CX3CR1(CreER)
189 ulatory associated protein of mTOR-mediated (RAPTOR-mediated) suppression, and altered kinase kinetic
192 tently, knockdown of rictor or mTOR, but not raptor, mimicked PP242 in decreasing FLIP(S) levels and
193 nd survival through forming 2 complexes with raptor (mTOR complex 1; mTORC1) or rictor (mTOR complex
194 inhibited phosphorylation of ribosomal S6, a raptor/mTOR complex 1 (mTORC1) target, without a compens
199 d unaltered ability to express CCR9, whereas Raptor (mTORC1)-deficient Treg were unable to upregulate
204 Using mice with T-cell-specific ablation of Raptor/mTORC1 or Rictor/mTORC2, we revealed that both mT
206 e peptides revealed that the most N-terminal Raptor N-terminal conserved domain (in particular residu
208 e we report that mTORC1-independent ('free') Raptor negatively regulates hepatic Akt activity and lip
209 d not inhibit the association of mTORC1 with Raptor nor did it affect AMP-activated protein kinase ac
211 ically, PKA directly phosphorylated mTOR and RAPTOR on unique serine residues, an effect that was ind
212 st the presence of two structured regions of Raptor: one in the N-terminal region and the other in th
213 acological or genetic inhibition of mTOR and Raptor or expression of a hypophosphorylated mutant vers
214 ither through adipocyte-specific deletion of Raptor or pharmacologic rapamycin treatment, were refrac
217 sed mice with conditional deletion of either Raptor or Rictor genes to determine potential contributi
219 myelination, we conditionally ablated either Raptor or Rictor in the oligodendrocyte lineage, in vivo
220 1 and S6K phosphorylation is maintained when raptor or rictor is depleted, suggesting that either mTO
222 iting mTOR, depleting its regulatory subunit raptor, or inducing hypoxia all trigger reactivation.
231 hosphorylation modulates the mTOR-raptor and raptor-PRAS40 interactions and augments mTORC1-associate
233 monstrate that ectopic expression of TOR and Raptor (regulatory-associated protein of mTOR), a protei
235 ering RNA (siRNA), we find that knockdown of raptor relieves autophagy and the eIF4E effector pathway
238 Cells with Nlk deletion or knock-in of the Raptor S863 phosphorylation mutants are defective in the
239 tified in vitro, we found that TBK1 promotes Raptor Ser877 phosphorylation in cells both basally and
245 systemic administration of the 4-1BB aptamer-raptor siRNA to mice downregulated mTORC1 activity in th
246 d with rapamycin, but not with 4-1BB aptamer-raptor siRNA, failed to reject a subsequent tumor challe
248 polyethylene glycol that was formulated with Raptor-small interfering RNA plus spironolactone in vivo
249 present separately in 5 additional fowl and raptor species, all of which are native to areas of Asia
250 istochemistry to evaluate this claim in five raptor species: the common buzzard (Buteo buteo), the ho
251 location to the lysosomal surface, where its Raptor subunit interacts with the Rag guanosine triphosp
252 hows the details of RagA/RagC binding to the RAPTOR subunit of mTORC1 and explains why only the RagA(
253 d in part by the Rag GTPases, which bind the raptor subunit of mTORC1 in an amino acid-stimulated man
254 It contains the atypical kinase mTOR and the RAPTOR subunit that binds to the Tor signalling sequence
259 osteronism expressed increased levels of the Raptor target, p70S6K, which provided a basis for invest
261 rthermore, we show that the scaffold protein raptor, that typically recruits mTOR substrates, is not
262 ry associated protein of the MTOR complex 1 (RAPTOR), the serine/threonine kinase V-Akt murine thymom
264 ze and questions: movements of an endangered raptor, the snail kite (Rostrhamus sociabilis plumbeus),
265 ctivity of mTORC1 through phosphorylation of Raptor Thr-908 and thus implicate a potential signaling
267 a phospho-specific antibody, we showed that Raptor Thr-908 is a novel in vivo phosphorylation site.
268 and movement of the key TORC1 component Kog1/Raptor to a single body near the edge of the vacuole.
269 rone (10(-9) to 10(-7) M) increased Akt/mTOR/Raptor to activate p70S6K and increase proliferation, vi
270 ated an siRNA targeting the mTORC1 component raptor to an aptamer that binds 4-1BB, a costimulatory m
271 tabilizes the interaction between PRAS40 and Raptor to inactive mTORC1-mediated hyper-glycolytic meta
273 ing component in mTORC1, and localization of Raptor to the nucleus results in nuclear mTORC1 activity
274 he use of rapid protein threading predictor (RAPTOR) to generate tertiary structures of closely relat
275 n one of the mTOR effector complex proteins, Raptor, to elucidate the role of mTORC1 in leukemia.
276 Here, we inactivate the core component, Raptor, to show that mTORC1 function is critical for mal
277 mutants lacking LST8, expression of TOR and RAPTOR, together with their upstream activator Rheb, was
278 genetic knockout of the major mTOR cofactors raptor (TOR complex 1 [TORC1]) and rictor (TORC2), we no
279 knockout of the major mTOR complex cofactors raptor (TORC1) and rictor (TORC2), we now show that TORC
281 and are no longer able to recruit RACK1 and Raptor, two TRAPP-interactive signaling proteins, sensit
284 atches propagate direct (high and low threat raptor vocalizations) or indirect (high and low threat c
285 ro Optimal inhibition of pulmonary arteriole Raptor was achieved by treatment with Staramine-monometh
286 the effect AMPK activation if either mTOR or Raptor was suppressed, indicating that the inhibitory ef
288 sing mice with T cell-restricted deletion of Raptor, we show that mTORC1 is selectively required for
289 On 4E-BP1, we found that cross-links with Raptor were clustered in the central region (amino acid
291 mTOR by enhancing PRAS40's association with RAPTOR, whereas AICAR blocked the cell cycle through pro
292 plex 1 (mTORC1) is defined by a core subunit Raptor, whereas mTORC2 lacks Raptor and, instead, has Ri
294 ) family members with the TORC1 subunit Kog1/Raptor, which in turn allow the TORC1 proximal kinase Sc
295 including mammalian target of rapamycin and raptor, which resulted in a stimulation of endothelial a
297 termine the structure of the supercomplex of Raptor with Rag-Ragulator at a resolution of 3.2 angstro